Western blot (WB): | 1:500-2000 |
Immunohistochemistry (IHC): | 1:50-400 |
Immunocytochemistry/Immunofluorescence (ICC/IF): | 1:50-400 |
(Boiling the paraffin sections in 10mM citrate buffer,pH6.0,or PH8.0 EDTA repair liquid for 20 mins is required for the staining of formalin/paraffin sections.) Optimal working dilutions must be determined by end user. |
Western blot analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: U87 whole cell lysates,
Lane 2: Mouse Brain tissue lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-PARK2/Parkin/PRKN antigen affinity purified polyclonal antibody (PB9307) at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody (Catalog # BA1054). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for PARK2/Parkin/PRKN at approximately 52,66 kDa. The expected band size for PARK2/Parkin/PRKN is at 52 kDa.
IHC analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307).
PARK2/Parkin/PRKN was detected in a paraffin-embedded section of mouse brain tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-PARK2/Parkin/PRKN Antibody (PB9307) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307).
PARK2/Parkin/PRKN was detected in a paraffin-embedded section of rat brain tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-PARK2/Parkin/PRKN Antibody (PB9307) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307).
PARK2/Parkin/PRKN was detected in a paraffin-embedded section of human intestinal cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-PARK2/Parkin/PRKN Antibody (PB9307) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Parkin using anti-Parkin antibody (PB9307).
Parkin was detected in immunocytochemical section of NEURO-2α Cell. Enzyme antigen retrieval was performed using IHC enzyme antigen retrieval reagent (AR0022) for 15 mins. The cells were blocked with 10% goat serum. And then incubated with 1μg/ml rabbit anti-Parkin Antibody (PB9307) overnight at 4°C. Biotinylated goat anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The section was developed using Strepavidin-Biotin-Complex (SABC)(Catalog # SA1022) with DAB as the chromogen.
Western blot analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: U87 whole cell lysates,
Lane 2: Mouse Brain tissue lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-PARK2/Parkin/PRKN antigen affinity purified polyclonal antibody (PB9307) at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody (Catalog # BA1054). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for PARK2/Parkin/PRKN at approximately 52,66 kDa. The expected band size for PARK2/Parkin/PRKN is at 52 kDa.
IHC analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307).
PARK2/Parkin/PRKN was detected in a paraffin-embedded section of mouse brain tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-PARK2/Parkin/PRKN Antibody (PB9307) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307).
PARK2/Parkin/PRKN was detected in a paraffin-embedded section of rat brain tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-PARK2/Parkin/PRKN Antibody (PB9307) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of PARK2/Parkin/PRKN using anti-PARK2/Parkin/PRKN antibody (PB9307).
PARK2/Parkin/PRKN was detected in a paraffin-embedded section of human intestinal cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-PARK2/Parkin/PRKN Antibody (PB9307) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Parkin using anti-Parkin antibody (PB9307).
Parkin was detected in immunocytochemical section of NEURO-2α Cell. Enzyme antigen retrieval was performed using IHC enzyme antigen retrieval reagent (AR0022) for 15 mins. The cells were blocked with 10% goat serum. And then incubated with 1μg/ml rabbit anti-Parkin Antibody (PB9307) overnight at 4°C. Biotinylated goat anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The section was developed using Strepavidin-Biotin-Complex (SABC)(Catalog # SA1022) with DAB as the chromogen.